Convergence Investment Partners, LLC AMRX — AMNEAL PHARMACEUTICALS INC

Ownership history in Convergence Investment Partners, LLC  ·  8 quarters on record

AI Ownership Summary

Convergence Investment Partners, LLC reported AMNEAL PHARMACEUTICALS INC (AMRX) in 8 quarterly 13F filings from 2024 Q2 through 2026 Q1. Peak portfolio weight reached 0.37% in 2024 Q3. The latest visible filing shows AMRX at 0.33% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this AMRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Convergence Investment Partners, LLC's position in AMNEAL PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

AMRX was reported at 0.33% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.37% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

AMRX stock page Convergence Investment Partners, LLC fund profile Convergence Investment Partners, LLC full holdings
How Convergence Investment Partners, LLC held AMRX — position size vs. price
% of Fund (quarterly)    AMRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 164,314 +17,884 +12.2% 0.33% $2.0M 2026-05-07 $13.72
2025 Q4 ADDED — — — 146,430 +49,513 +51.1% 0.37% $1.8M 2026-02-05 $14.77
2025 Q3 REDUCED 39.3% +29.0% ❌ 96,917 -62,852 -39.3% 0.22% $970K 2025-11-04 $11.35
2025 Q2 ADDED — — — 159,769 +4,650 +3.0% 0.33% $1.3M 2025-08-01 $7.83
2025 Q1 REDUCED 25.4% -3.5% ✅ 155,119 -52,890 -25.4% 0.36% $1.3M 2025-05-06 $7.18
2024 Q4 ADDED — — — 208,009 +41,161 +24.7% 0.37% $1.6M 2025-01-31 $8.26
2024 Q3 ADDED — — — 166,848 +23,633 +16.5% 0.37% $1.4M 2024-10-29 $8.55
2024 Q2 INITIATED — — — 143,215 — — 0.27% $909K 2024-08-01 $7.18

🏢 Other funds also holding AMRX

As of 2026 Q1 — sorted by position size

Westshore Wealth, LLC 3Y 5.99% TPG GP A, LLC 3Y 4.17% Quartz Partners, LLC 2.15% Phocas Financial Corp. 3Y 7Y 1.96% BlackBarn Capital Partners LP 1.65% Rubric Capital Management LP 3Y 7Y 1.45% Nantahala Capital Management, LLC 3Y 7Y 1.3% Penn Capital Management Company, LLC 3Y 7Y 1.15% PFM Health Sciences, LP 3Y 7Y 1.05% Freemont Management S.A. 3Y 0.6%

FAQ About Convergence Investment Partners, LLC and AMRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Convergence Investment Partners, LLC reported owning AMRX?

Convergence Investment Partners, LLC reported AMRX across 8 quarterly 13F filings, from 2024 Q2 through 2026 Q1.

What was the largest reported AMRX position in Convergence Investment Partners, LLC's portfolio?

The largest reported portfolio weight for AMRX was 0.37% in 2024 Q3.

What is the latest reported AMRX position on this page?

The most recent filing on this page is 2026 Q1, when Convergence Investment Partners, LLC reported 164,314 shares, equal to 0.33% of portfolio, with an estimated market value of $2.0M.

What does the chart on this AMRX ownership page compare?

The chart compares Convergence Investment Partners, LLC's quarterly AMRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Convergence Investment Partners, LLC time their AMRX position?

Based on 13F filing dates vs. subsequent AMRX price moves, Convergence Investment Partners, LLC correctly timed 2 out of 7 reported position changes (29%). The annualised alpha on AMRX relative to SPY over the holding period was +20.5%.

← Back to Convergence Investment Partners, LLC Holdings